iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Cash & Current Investments of $549.6 million for Q1 2026, up 5.58% year-over-year from $520.6 million in Q1 2025, and down 5.85% quarter-over-quarter from $583.8 million in Q4 2025.
iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Cash & Current Investments for 12 consecutive years, with $549.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 5.58% year-over-year to $549.6 million; the TTM figure through Mar 2026 stood at $549.6 million (up 5.58% YoY), while the FY2025 annual figure was $583.8 million, up 9.0% from the prior year.
- Cash & Current Investments fell to $549.6 million in Q1 2026 per IRTC's latest filing, from $583.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $583.8 million in Q4 2025 and bottomed at $133.8 million in Q4 2023.
- Historically, Cash & Current Investments has averaged $363.3 million across 5 years, with a median of $450.9 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 40.3% — and 2024, when it soared 300.37%.
- iRhythm Holdings' Cash & Current Investments stood at $213.1 million in 2022, then sank by 37.24% to $133.8 million in 2023, then jumped by 300.37% to $535.6 million in 2024, then grew by 9.0% to $583.8 million in 2025, then decreased by 5.85% to $549.6 million in 2026.
- Business Quant data shows IRTC's Cash & Current Investments at $549.6 million in Q1 2026, $583.8 million in Q4 2025, and $472.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | 591.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 591.27 Mn |
| Mar 31, 2026 | 549.62 Mn |
| Dec 31, 2025 | 583.76 Mn |
| Sep 30, 2025 | 472.07 Mn |
| Jun 30, 2025 | 450.88 Mn |
| Mar 31, 2025 | 520.59 Mn |
| Dec 31, 2024 | 535.55 Mn |
| Sep 30, 2024 | 522.03 Mn |
| Jun 30, 2024 | 561.46 Mn |
| Mar 31, 2024 | 569.09 Mn |
| Dec 31, 2023 | 133.76 Mn |
| Sep 30, 2023 | 158.47 Mn |
| Jun 30, 2023 | 164.74 Mn |
| Mar 31, 2023 | 176.34 Mn |
| Dec 31, 2022 | 213.14 Mn |
| Sep 30, 2022 | 203.54 Mn |
| Jun 30, 2022 | 204.49 Mn |
| Mar 31, 2022 | 156.59 Mn |
| Dec 31, 2021 | 221.71 Mn |
| Sep 30, 2021 | 221.80 Mn |